Papillary Thyroid Cancer and Coexisting Autoimmune Thyroiditis

Abstract

Histological findings often display an association between papillary thyroid carcinomas (PTC) and autoimmune thyroiditis (AIT) and so differ significantly from follicular thyroid carcinomas (FTC). The aim of this interdisciplinary, retrospective study was to evaluate the association of AIT in patients with PTC and FTC and a control group of benign nodular goiters. One hundred thyroidectomies with histologically confirmed differentiated thyroid carcinomas, 67 with PTC and 33 with FTC, were submitted for examination. The two control groups consisted of 60 patients with euthyroid nodular goiter, displaying no signs for malignancy (no surgery) and 100 patients (second control group) with surgery of a benign nodular goiter. Controls were collected to obtain data about the incidence of significantly increased TPOAbs in the first group and of lymphocytic infiltrates (LI) in the second group. High TPOAbs were found in 35% (23/67) of patients with PTC. LI were detected by histology in 48% (32/67) of PTC. Ten patients (10/32) of this group showed the clinical and histological manifestation of a classic AIT with diffuse dense LI as well as diffuse hypoechogeneity in ultrasonography. In 7/32 cases, the histological report described focal dense LI (fAIT) and in 15/32 cases scant scattered LI. AIT and fAIT, together 25% of all PTC (17/67), showed germinal centers and can therefore be characterized as chronic autoimmune thyroiditis. In this group, high TPOAb could be detected in 94% (16/17). Scan scattered LI without germinal centers (15/32) do not represent a fAIT, although TPOAb are high in 47% (7/15). The younger age group (<45 years) showed significantly more often high TPOAbs (p<0.023) in comparison with the age-group older than 60 years. In contrast to PTC, only 4/33 (12%) patients with FTC had high TPOAb levels. We conclude that in contrast to benign euthyroid goiters and to FTC, different degrees of LI are often associated with high TPOAb levels and seem to be significantly increased in PTC, particularly prominent in younger age. There is a high coincidence between LI and high TPOAb levels. In the presence of hypoechoic thyroid nodule, signs of thyroid autoimmunity such as the presence of high TPOAbs, lymphocytic infiltration in cytology, and/or characteristic ultrasonic features, are arguments that might favor the decision for surgery if a cytologically indeterminate thyroid nodule is found and focal autonomy is excluded by szintiscan.

Key words

PTC and AIT - focal AIT - lymphocytic infiltration - papillary thyroid cancer

• References

• 1 Ajjan RA, Weetman AP. The Pathogenesis of Hashimoto’s thyroiditis: Further Developments in our Understanding. Horm Metab Res 2015; 47: 702-710
• 2 Cipolla C, Sandonato L, Graceffa G. et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005; 71: 874-878
• 3 Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasmas to Hashimoto disease of thyroid gland. AMA. Arch Surg 1955; 70: 291-297
• 4 Duntas LH. The Role of Iodine and Selenium in Autoimmune Thyroiditis. Horm Metab Res 2015; 47: 721-726
• 5 Ehlers M, Schott M. Hashimoto’s thyroiditis and papillary thyroid cancer: Are they immunologically linked?. Trends Endocrinol Metab 2014; 25: 656-664
• 6 Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chromic lymphocytic thyroiditis. N Engl Med 1985; 212: 601-604
• 7 Pisanu A. Pius Cois A. et al. Coexisting Hashimoto’s thyroiditis with differentiated thyroid cancer and benign thyroid diseases: Indications for thyroidectomy. Chin Ital 2003; 55: 365-372
• 8 Mariotti S, Marziani B, Matta V. et al. Hashimoto thyroiditis and thyroid Cancer: Results of a Echographic, Cytological and Histological Study. Horm Res 2007; 68 (Suppl. 03) 21-91
• 9 Ohmori N, Miyakawa M, Ohmori K. et al. Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto thyroiditis. Intern Med 2007; 46: 547-550
• 10 Rhoden KJ, Unger K, Salvatore G. et al. RET/papillary thyroid cancer Rearrangement in nonneoplastic thyrocytes: Follicular cells of Hashimoto thyroiditis shave low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 2006; 91: 2414-2423
• 11 Kebebew E, Treseler P, Ituarte P. et al. Coexisting Chronic Lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001; 25: 632-637
• 12 Nikiforov YE. Editorial: RET/PTC Rearrengement – A Link between Hashimoto’s thyroiditis and thyroid Cancer or Not. J Clin Endocrinol Metab 2006; 91: 2040-2042
• 13 Ruffilli I, Ferrari SM, Colaci M. et al. IP-10 in Autoimmune Thyroiditis. Horm Metab Res 2014; 46: 597-602
• 14 Rostamzadeh D, Dabbaghmanesh MH, Shabani M. et al. Expression Profile of Human Fc Receptor-Like 1, 2 and 4 molecules in peripheral blood mononuclear cells of patients with Hashimoto’s thyroiditis and Graves’ Disease. Horm Metab Res 2015; 47: 693-698
• 15 Kang DY, Kim KH, Kim JM. et al. High prevalence of RET, RAS and ERK expression in Hashimoto’s thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 2007; 17: 1031-1038
• 16 Lin LH, Bakhos R, Wojcik EM. Concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis. Semin Diag Pathos 2001; 18: 99-103
• 17 Kong YM, Brown NK, Morris GP. et al. The essential role of circulating thyroglobulin in maintaining dominance of natural Regulatory T Cell function to prevent autoimmune thyroiditis. Horm Metab Res 2015; 47: 711-720
• 18 Rendina D, De Palma D, De Filippo G. et al. Prevalence of simple nodular goiter and hashimoto’s thyroiditis in current, previous, and never smokers in a geographical area with mild iodine deficiency. Horm Metab Res 2015; 47: 214-219